title: Cost efficiency in the prospective diagnosis and follow-up of polyomavirus allograft nephropathy.
abstract: Evaluation of urine cytology (UC) for decoy cells and quantitative determinations of viruria (urine viral load [UPCR])and viremia (viral load in blood [VLB]) have been proposed as surrogate markers of polyomavirus allograft nephropathy (PVAN). In this study, we present the experience with the concurrent evaluation of UC, UPCR, and VLB in 349 patients (940 sets of samples). Results were correlated with each other and with a previous, concurrent, or subsequent biopsy diagnosis of PVAN. Patients were followed up for a mean of 27 months posttransplantation. We conclude that both UC and UPCR are useful for screening of renal transplant recipients. Simultaneous performance of both UC and UPCR does not add useful clinical information. In patients with positive UC, performance of UPCR, however, can allow for the distinction between BK and JC polyoma viruses. Quantitative measurement of viremia is not indicated in patients lacking viruria because no patients with PVAN present with this combination of findings. In patients with viruria, a positive viremia strongly correlates with PVAN. Rationale selection of screening protocols based on the current knowledge of the infection and tailored to the available laboratory capabilities in each transplantation center can optimize the use of resources.
authors.affiliation: Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
authors.forename: C
authors.initials: C
authors.lastname: Drachenberg
authors.forename: H H
authors.initials: HH
authors.lastname: Hirsch
authors.forename: J C
authors.initials: JC
authors.lastname: Papadimitriou
authors.forename: P
authors.initials: P
authors.lastname: Mozafari
authors.forename: R
authors.initials: R
authors.lastname: Wali
authors.forename: J D
authors.initials: JD
authors.lastname: McKinney
authors.forename: J
authors.initials: J
authors.lastname: Nogueira
authors.forename: C B
authors.initials: CB
authors.lastname: Cangro
authors.forename: S
authors.initials: S
authors.lastname: Mendley
authors.forename: D K
authors.initials: DK
authors.lastname: Klassen
authors.forename: E
authors.initials: E
authors.lastname: Ramos
mesh_terms: D001706:Biopsy / Q000191:economics; D003362:Cost-Benefit Analysis; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000191:economics* / Q000473:pathology; D008396:Maryland; D027601:Polyomavirus Infections / Q000191:economics* / Q000453:epidemiology; D014184:Transplantation, Homologous; D019562:Viral Load; D014766:Viremia / Q000191:economics / Q000453:epidemiology